Skip to main content

Table 2 Crude and adjusted HRs of cardiovascular outcomes and all-cause mortality

From: Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study

Outcome

Number of severe hypoglycemia

N

Event

Incidence rate (per 1000 patient-years)

HR (95% CI)

P for trend

Crude

Sex- and age adjusted

Multivariablea

Myocardial infarction

0

1,548,437

58,529

6.7

Reference

Reference

Reference

< 0.001

1

15,992

945

12.1

2.36 (2.21–2.51)

1.83 (1.72–1.96)

1.56 (1.46–1.64)

 

2

2543

182

16.1

3.12 (2.70–3.61)

2.31 (1.99–2.67)

1.86 (1.61–2.15)

 

3 or more

1125

72

15.5

2.99 (2.97–3.77)

2.39 (1.90–3.01)

1.86 (1.48–2.35)

 

Stroke

0

1,548,437

58,529

6.7

Reference

Reference

Reference

< 0.001

1

15,992

1304

16.9

2.53 (2.40–2.67)

1.78 (1.68–1.88)

1.54 (1.46–1.63)

 

2

2543

228

20.2

3.03 (2.66–3.45)

1.97 (1.73–2.24)

1.62 (1.42–1.84)

 

3 or more

1125

115

24.9

3.74 (3.11–4.49)

2.69 (2.25–3.24)

2.14 (1.78–2.57)

 

Heart failure

0

1,548,437

52,485

6.0

Reference

Reference

Reference

< 0.001

1

15,992

1423

18.4

3.13 (2.97–3.30)

2.09 (1.99–2.21)

1.68 (1.60–1.78)

 

2

2543

283

25.2

4.33 (3.85–4.87)

2.66 (2.36–2.99)

2.00 (1.78–2.25)

 

3 or more

1125

139

30.5

5.31 (4.49–6.27)

3.65 (3.09–4.31)

2.59 (2.19–3.06)

 

All-cause death

0

1,548,437

146,332

16.5

Reference

Reference

Reference

< 0.001

1

15,992

5058

63.3

3.88 (3.77–3.99)

2.46 (2.39–2.53)

1.98 (1.93–2.04)

 

2

2543

1074

91.6

5.63 (5.31–3.98)

3.24 (3.05–3.44)

2.39 (2.25–2.53)

 

3 or more

1125

572

119.0

7.37 (6.79–8.00)

4.73 (4.35–5.13)

3.28 (3.02–3.56)

 
  1. aAdjusted for age, sex, living place (urban or rural), income level, anti-diabetic drugs, the presence of hypertension, dyslipidemia, and major comorbidities (malignancy, liver cirrhosis, ESRD, and COPD)